The company announced a formal plan to explore strategic alternatives for the segment, which has resulted in the spin-off.
Dedicated Devices for HYQVIA [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Reduce the Number ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback